Automated description from the Alliance of Genome Resources (Release 7.0.0)
Predicted to enable histone H3R26 arginine deiminase activity; nuclear estrogen receptor binding activity; and protein homodimerization activity. Acts upstream of or within cellular response to leukemia inhibitory factor. Predicted to be part of euchromatin. Predicted to be active in cytoplasm and nucleus. Is expressed in several structures, including Harderian gland; brain; early embryo; major salivary gland; and reproductive system. Orthologous to human PADI2 (peptidyl arginine deiminase 2).